Overactive Bladder - Results from #320

Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment. December 25, 2022

Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report. December 25, 2022

Overactive Bladder Patients With and Without Urgency Incontinence: A Spectrum of One Condition or Different Phenotypes? December 25, 2022

Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy. December 18, 2022

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia. December 18, 2022

Unraveling the impact of Lactobacillus spp. and other urinary microorganisms on the efficacy of mirabegron in female patients with overactive bladder. December 11, 2022

CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis. December 11, 2022

Determining patient preferences in the treatment of medication-refractory overactive bladder. December 11, 2022

National Trends in Third-Line Treatment for Overactive Bladder Among Commercially Insured Women, 2010-2019. December 4, 2022

Vaginal Hormone Therapy for Conditions of the Lower Urinary Tract. December 4, 2022

Impact of Weight Gain on Surgical Outcomes and Quality of Life Among Women After Sling Surgeries. December 4, 2022

Feasibility and clinical implications of 3-day bladder diary derived classification of female storage lower urinary tract symptoms. November 27, 2022

Urobiome changes differ based on OAB treatment in adult females. November 27, 2022

Comparison of different types of therapy for overactive bladder: A systematic review and network meta-analysis. November 27, 2022

Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial. November 20, 2022

Quality of life and sexual function evaluation in women with urogynecological diseases analyzed with telemedicine during the Covid period: the beginning of a new era? November 20, 2022

Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review. November 20, 2022

Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season November 14, 2022

Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review. November 13, 2022

Sacral neuromodulation: Rechargeable versus non-rechargeable device. What would the patient preferences be in France? November 13, 2022

Page 17 of 122